PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2012 | 7 | 1 | 34-37
Article title

Somatostatine analogue in nonoperative treatment of posttraumatic pancreatic pseudocyst in a child: a case report

Content
Title variants
Languages of publication
EN
Abstracts
EN
Pancreatic pseudocyst is a complication of pancreatic trauma. We describe improved nonoperative treatment of patient with posttraumatic pancreatic pseudocyst with somatostatin analogue. A 9-year-old girl was admitted to our hospital after blunt abdominal trauma with handlebar. Three weeks after abdominal trauma, pancreatic pseudocyst developed. Nonoperative treatment of posttraumatic pancreatic pseudocyst (the largest dimensions 70 × 55 × 65 mm) with somatostatin analogue, octreotide acetate, was applied for the next 52 days. The patient was followed up for 24 months after the discontinuation of octreotide and there were no recurrence of pancreatic pseudocyst. Somatostatin analogue could be usefull in the nonoperative treatment of posttraumatic pancreatic pseudocysts in children.
Publisher
Journal
Year
Volume
7
Issue
1
Pages
34-37
Physical description
Dates
published
1 - 2 - 2012
online
24 - 11 - 2011
References
  • [1] Mulligan C, Howell C, Hatley R, Martindale R, Clark J. Conservative management of pediatric pancreatic pseudocyst using octreotide acetate. Am Surg 1995;61:206–209
  • [2] Chen KH, Hsu HM, Hsu GC, Chen TW, Hsieh CB, Liu YC, et al. Therapeutic strategies for pancreatic pseudocysts: experience in Taiwan. Hepatogastroenterology 2008;55:1470–1474
  • [3] Baca I, Schulz C, Gotzen V. Technique of laparoscopic pancreatocysto-jejunostomy. Zentralbl Chir 1998;23:183–187
  • [4] Booth FV, Flint LM. Pancreatoduodenal trauma. In Border Jed. Blunt Multiple Trauma. New York, NY, Marcel Dekker; 1990:497–509
  • [5] Arkovitz MS, Johnson N, Garcia VF. Pancreatic trauma in children: mechanisms of injury. J Trauma 1997;42:49–53 http://dx.doi.org/10.1097/00005373-199701000-00009[Crossref]
  • [6] Mattix KD, Tataria M, Holmes J, Kristoffersen K, Brown R, Groner J, et al. Pediatric pancreatic trauma: predictors of nonoperative menagement failure and associated outcomes. J Pediatr Surg 2007;42:340–344 http://dx.doi.org/10.1016/j.jpedsurg.2006.10.006[WoS][Crossref]
  • [7] Habashi S, Draganov PV. Pancreatic pseudocyst. World J Gastroenterol 2009; 15:38–47. http://dx.doi.org/10.3748/wjg.15.38[Crossref]
  • [8] Yeo CJ, Bastidas JA, Lynch-Nyhan A, Fishman EK, Zinner MJ, Cameron JL. The natural history of pancreatic pseudocysts documented by computed tomography. Surg Gynecol Obstet 1990;170:411–417
  • [9] Cheruvu CV, Clarke MG, Prentice M, Eyre-Brook IA. Conservative treatment as an option in the management of pancreatic pseudocyst. Ann R Coll Surg Engl 2003;85:313–316 http://dx.doi.org/10.1308/003588403769162413[Crossref]
  • [10] Suga H, Tsuruta O, Okabe Y, Saitoh F, Noda T, Yoshida H, et al. A Case of mediastinal pancreatic pseudocyst successfully treated with somatostatin analogue. Kurume Med J 2005;52:161–164 http://dx.doi.org/10.2739/kurumemedj.52.161[Crossref]
  • [11] Yasuda H, Ino Y, Igarashi H, Arita Y, Nakamuta M, Sumii T, et al. A case of pancreatic pleural effusion and mediastinal pancreatic pseudocyst: management by a somatostatin analogue octreotide. Pancreas 1999;19:410–412 http://dx.doi.org/10.1097/00006676-199911000-00015[Crossref]
  • [12] Németh AM. Somatostatin in the treatment of pancreatic diseases. Orv Hetil 2002; 143:1099–1108
Document Type
Publication order reference
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_s11536-011-0108-z
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.